First Solar, Inc. (FSLR) — Q2 2026 Earnings Preview

Company

First Solar, Inc. (FSLR)

Upcoming Earnings Date

July 30, 2026 (After Market Close)

Reporting Period

Q2 2026

Prepared

July 29, 2026

Last Earnings

Q1 2026 — April 30, 2026 (Beat)

Sector ETF Benchmark

TAN (Invesco Solar ETF)

1. Earnings Preview

Key Takeaway: The setup is constructive but binary — consensus is a manageable bar, but the Section 232 polysilicon tariff decision (expected early August) is the single biggest swing factor that could reprice the stock materially in either direction regardless of the print itself.

Heading into Q2 2026, First Solar faces a consensus bar that looks achievable: the Street is modeling ~$1.07B in revenue and ~$2.85 in operating EPS, both roughly in line with management’s own Q2 guidance of volumes and Adjusted EBITDA in the same range as Q1 (which itself came in above the top end of the company’s own preview). Management’s tone on the Q1 call was notably confident — full-year 2026 guidance was reaffirmed unchanged, U.S. facilities are running at near-full utilization, and the CuRe technology rollout is on track — suggesting the bar is not set aggressively high. Estimate revisions have been broadly stable since the Q1 print, with the as-of-May-7 consensus nearly identical to current levels, implying the Street has largely digested the Q1 beat without chasing numbers higher. The stock surged from ~$202 at the Q1 print to an all-time high of ~$321 on June 3 before reversing sharply to ~$199 today, driven by a securities class action lawsuit filing and Section 232 timeline uncertainty — meaning the stock has already given back its post-earnings gains and is no longer pricing in a beat. The wildcard is the

Section 232 polysilicon tariff proclamation, now expected in early August: management’s current guidance assumes Section 122 tariffs expire in July with no replacement modeled for finished goods, creating meaningful upside if 301 tariffs are implemented and downside if the policy disappoints. With ~2 GW of Southeast Asian fully-finished module capacity and incremental bookings contingent on the outcome, this binary catalyst — not the Q2 print itself — is likely to dominate the stock’s reaction.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus is a moderate bar — revenue and EPS estimates are essentially flat vs. Q1 actuals, and the bigger swing factor is 45X IRA credit volume and shipment mix, which drove the Q1 upside surprise and could do so again.

Table 1 — Current Quarter Snapshot (Q2 2026)

KPI

Q1 2026 Actual

Q2 2025 Actual

Q2 2026 Consensus Est.

YoY Change

Q2 2026 Guidance

Cons. vs. Guidance

Net Sales ($M)

$1,044

$1,097

$1,067

-2.7%

~Q1 range

~In line

Op. EPS (Incl. 45X) ($)

$3.22

$3.18

$2.85

-10.4%

~Q1 EBITDA range

~In line

Gross Profit Incl. 45X ($M)

$486

$500

$456

-8.8%

N/A (EBITDA guided)

N/A

Total Shipments (MW)

3,800

3,554

3,791

+6.7%

3.4–4.0 GW

~In line / slight low end

IRA Credits / 45X ($M)

$418

$377

$408

+8.2%

N/A (volume-driven)

N/A

Adj. EBITDA ($M)

$520

$538

$477

-11.3%

~Q1 range (~$520M)

~-8% vs. guidance mid

Net Bookings (GWh)

1.6

-0.7 (net cancellations)

1.4

N/M

N/A

N/A

Source: Visible Alpha Consensus and Actuals Data. All consensus figures as of latest available (July 2026). Q2 2026 guidance per Q1 2026 earnings call (April 30, 2026). YoY change compares Q2 2026 consensus vs. Q2 2025 actual.

Table 2 — Beat/Miss History (Last 8 Quarters)

Top KPI #1: Net Sales ($M)

Quarter

Reported ($M)

Consensus ($M)

Surprise %

Result

Q1 2026

$1,044

$1,029

+1.5%

Beat

Q4 2025

$1,683

$1,572

+7.1%

Beat

Q3 2025

$1,595

$1,593

+0.1%

Beat

Q2 2025

$1,097

$1,046

+4.9%

Beat

Q1 2025

$845

$848

-0.4%

Miss

Q4 2024

$1,514

$1,485

+2.0%

Beat

Q3 2024

$888

$1,062

-16.4%

Miss

Q2 2024

$1,010

$937

+7.8%

Beat

Top KPI #2: Operating EPS — Diluted, Including 45X ($)

Quarter

Reported ($)

Consensus ($)

Surprise %

Result

Q1 2026

$3.22

$2.76

+16.7%

Beat

Q4 2025

$4.84

$5.24

-7.6%

Miss

Q3 2025

$4.24

$4.27

-0.7%

Miss

Q2 2025

$3.18

$2.67

+19.1%

Beat

Q1 2025

$1.95

$2.46

-20.7%

Miss

Q4 2024

$3.65

$4.72

-22.6%

Miss

Q3 2024

$2.91

$3.13

-7.0%

Miss

Q2 2024

$3.25

$2.69

+20.8%

Beat

Pattern: Revenue beats have been consistent (6 of 8 quarters), but EPS has been more volatile — FSLR has missed EPS in 5 of the last 8 quarters, largely driven by 45X credit timing, international underutilization charges, and mix shifts. The Q1 2026 EPS beat (+16.7%) was the largest positive surprise in recent history, driven by higher-than-expected 45X-qualifying volumes and significantly lower freight costs. The Q2 2026 consensus EPS of $2.85 implies a meaningful step-down from Q1’s $3.22, which may be conservative given the same U.S. utilization dynamics.

Source: Visible Alpha Consensus and Actuals Data.

3. Guidance & Commentary Evolution

Key Takeaway: Full-year 2026 guidance was reaffirmed unchanged on the Q1 call; no post-earnings revisions have been issued, and management tone remains confident on U.S. execution while flagging Section 232 and Section 122 tariff expiry as the key unmodeled variables.

Metric

Initial Guidance (Q1 2026 Earnings Call, Apr 30)

Revised Guidance

Current Consensus

Note

FY 2026 Net Sales ($B)

$4.9B – $5.2B

$5.07B

Unchanged; consensus at midpoint. Guidance reaffirmed Apr 30, 2026.

FY 2026 Volume Sold (GW)

17.0 – 18.2 GW

17.7 GW

Unchanged; consensus near midpoint.

Q2 2026 Volume (GW)

~3.4 – 4.0 GW

3.79 GW

Consensus at low end of guidance range; slight conservatism.

Q2 2026 Adj. EBITDA

~Same range as Q1 (~$520M)

$477M

Consensus ~8% below guidance midpoint — potential cushion if 45X volumes repeat.

FY 2026 Adj. EBITDA ($B)

N/A (quarterly guided)

$2.64B

Implied from quarterly guidance; no explicit FY EBITDA range given.

Section 232 / Tariff Assumption

Sec. 122 tariffs expire ~July; no replacement modeled for finished goods

N/A

Key unmodeled upside: 301 tariffs on finished modules. Decision now expected early August.

SC Finishing Facility

On track for H2 2026 production start

N/A

Execution milestone; any delay would be a negative signal.

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates have been remarkably stable since the Q1 print — the Street has not chased numbers higher despite the beat, suggesting modest cushion heading into Q2 rather than an elevated bar. FY 2026 consensus is essentially unchanged, implying the market is waiting for Section 232 clarity before revising meaningfully.

KPI & Period

Est. as of May 7, 2026 (Post-Q1 Baseline)

Current Consensus (Jul 2026)

Estimate Δ (%)

Initial Guidance (Q1 Call)

Current Guidance

Guidance Δ

Cons. vs. Guidance (%)

Net Sales — Q2 2026

$1,068M

$1,067M

-0.1%

~Q1 range (~$1.04B)

Unchanged

+2.6% above Q1 actual

Net Sales — FY 2026

$5,078M

$5,071M

-0.1%

$4.9B – $5.2B

Unchanged

At midpoint

Op. EPS (Incl. 45X) — Q2 2026

$2.80

$2.85

+1.8%

~Q1 EBITDA range

Unchanged

~11% below Q1 actual ($3.22)

Op. EPS (Incl. 45X) — FY 2026

$17.68

$17.51

-1.0%

N/A (no explicit FY EPS guide)

N/A

N/A

Total Shipments — Q2 2026 (MW)

3,870

3,791

-2.0%

3,400 – 4,000 MW

Unchanged

At low end of range

IRA Credits (45X) — Q2 2026 ($M)

$397M

$408M

+2.8%

N/A

N/A

N/A

Adj. EBITDA — Q2 2026 ($M)

$466M

$477M

+2.4%

~$520M (same as Q1)

Unchanged

~-8% below guidance mid

The near-zero estimate drift since the Q1 print is notable: the Street has not revised up despite the Q1 beat, nor revised down despite the stock’s -38% drawdown from its June 3 peak. This suggests consensus is anchored to management’s unchanged guidance rather than reacting to macro or policy noise. The key divergence is Adj. EBITDA, where consensus ($477M) sits ~8% below management’s own Q2 guidance midpoint (~$520M) — a gap that represents potential upside if 45X-qualifying volumes again surprise to the high side as they did in Q1.

Source: Visible Alpha Consensus and Actuals Data. Post-Q1 baseline as of May 7, 2026 (5 trading days after April 30, 2026 earnings).

5. Stock Performance

Key Takeaway: FSLR surged +57% from the Q1 earnings date to its June 3 all-time high of ~$321, driven by Section 232 optimism and multiple expansion, before reversing sharply -38% to ~$199 today on lawsuit filing and policy timeline delays — the stock has now given back all post-earnings gains and is trading below its pre-earnings level, creating an asymmetric setup if Q2 results are solid.

FSLR vs. TAN (Invesco Solar ETF) vs. S&P 500 (SPY) — Indexed to 100 at Q1 2026 Earnings (April 30, 2026). Source: Yahoo Finance / Stock Price Data.

Performance Summary (April 30 – July 30, 2026):

6. Material News & Developments

Key Takeaway: The most important development since Q1 earnings is the Section 232 polysilicon tariff decision delay to early August — this single binary catalyst, not the Q2 print, is likely to dominate the stock’s trajectory over the next 30 days.

7. Peer Commentaries — Q2 2026 Read-Throughs

Key Takeaway: Peer commentary from Q2 2026 reporting season is broadly constructive for utility-scale solar demand (NEE adding 3.6 GW to backlog, ARRY at record $2.4B order book) but signals continued residential softness (ENPH U.S. sell-through -34% YoY) and highlights 45X credit monetization and FEOC compliance as key differentiators — all themes that directly benefit FSLR’s utility-scale, domestic-manufacturing positioning.

NextEra Energy (NEE) — Q2 2026 Earnings (July 24, 2026)

Relevance: NEE is the largest U.S. utility-scale solar developer and a key FSLR customer proxy. Its Q2 2026 results provide the most direct read-through on utility-scale solar demand heading into FSLR’s print.

Enphase Energy (ENPH) — Q2 2026 Earnings (July 28, 2026)

Relevance: ENPH is primarily residential/distributed solar, but its commentary on 45X credits, tariff dynamics, FEOC compliance, and U.S. solar market conditions provides relevant read-throughs for FSLR’s policy and demand environment.

Array Technologies (ARRY) — Q1 2026 Earnings (May 6, 2026) & JP Morgan Conference (May 18, 2026)

Relevance: ARRY is a leading utility-scale solar tracker manufacturer — its order book and demand commentary are a direct proxy for utility-scale solar project activity, which drives FSLR module demand.

SolarEdge (SEDG) — Q1 2026 Earnings (May 6, 2026) & Conferences (May 14 & 28, 2026)

Relevance: SEDG is primarily a residential/C&I inverter company, but its commentary on FEOC restrictions, 45X credits, domestic content, and U.S. solar market dynamics provides relevant policy read-throughs for FSLR.

Canadian Solar (CSIQ) — Q1 2026 Earnings (May 14, 2026)

Relevance: CSIQ is a direct competitor to FSLR in the U.S. utility-scale module market, though it uses crystalline silicon technology. Its commentary on U.S. manufacturing ramp, module pricing, and tariff dynamics is a direct competitive read-through.

8. Insider Transaction Activity

Key Takeaway: All open-market sales since Q1 earnings are 10b5-1 planned sales — no discretionary selling detected. The absence of any open-market buys despite the stock’s -38% drawdown from its June 3 peak is notable but not alarming given the 10b5-1 plan structure. Director equity awards in late June are routine compensation.

Name

Title

Transaction Type

Shares

Date

Note

Buehler, Patrick J.

Chief Product Officer

Open Market Sale

3,000

Jun 2, 2026

10b5-1 Planned Sale

Stockdale, Caroline

Chief People & Comm. Officer

Open Market Sale

10,628

May 28, 2026

10b5-1 Planned Sale

Widmar, Mark R.

CEO & Director

Open Market Sale

1,977

May 22, 2026

10b5-1 Planned Sale

Widmar, Mark R.

CEO & Director

Open Market Sale

4,815

May 21, 2026

10b5-1 Planned Sale

Verma, Kuntal Kumar

Chief Manufacturing Officer

Open Market Sale

582

May 21, 2026

10b5-1 Planned Sale

Widmar, Mark R.

CEO & Director

Open Market Sale

9,926

May 11, 2026

10b5-1 Planned Sale

Widmar, Mark R.

CEO & Director

Open Market Sale

1,300

May 13, 2026

10b5-1 Planned Sale

Verma, Kuntal Kumar

Chief Manufacturing Officer

Open Market Sale

2,216

May 11, 2026

10b5-1 Planned Sale

Verma, Kuntal Kumar

Chief Manufacturing Officer

Open Market Sale

1,455

May 13, 2026

10b5-1 Planned Sale

ANTOUN, Georges

Chief Commercial Officer

Open Market Sale

566

May 5, 2026

Discretionary (no 10b5-1 flag); RSU vesting-related

Bradley, Alexander R.

Chief Financial Officer

Open Market Sale

498

May 5, 2026

RSU vesting-related (same-day as M transaction)

Multiple Directors (8)

Board of Directors

Equity Award (A)

223–313 each

Jun 30, 2026

Routine annual director equity compensation; not open-market purchases

Analysis: The insider transaction picture is clean — all material sales by the CEO (Widmar), Chief Manufacturing Officer (Verma), Chief People Officer (Stockdale), and Chief Product Officer (Buehler) are flagged as 10b5-1 planned sales, meaning they were pre-scheduled and are not discretionary signals. The cluster of RSU vesting-related sales on May 4–5 (immediately post-Q1 earnings) across nearly all C-suite officers is standard post-earnings vesting activity. The June 30 director equity awards are routine annual compensation. No open-market buys have been filed despite the stock’s -38% drawdown from its June 3 peak — this is not alarming given the 10b5-1 plan structure and blackout period constraints, but worth monitoring if the stock continues to decline.

Source: SEC Form 4 filings via Insider Transaction Data.

Disclosures & Data Sources